Sartorius Stedim Biotech SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013154002
EUR
165.00
-2.05 (-1.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,967.50
2,780.00
2,775.50
3,492.70
2,886.98
1,910.08
1,440.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,967.50
2,780.00
2,775.50
3,492.70
2,886.98
1,910.08
1,440.57
Raw Material Cost
1,622.20
1,573.30
1,541.50
1,658.20
1,333.97
906.76
692.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
855.90
852.10
829.50
806.90
664.51
486.32
393.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
152.70
158.90
121.10
41.00
23.68
37.73
19.95
Selling and Distribution Expenses
664.80
650.50
619.30
602.60
531.60
394.58
319.56
Other Expenses
-87.60
-87.46
-82.37
-71.55
-57.77
-43.96
-33.39
Total Expenditure (Excl Depreciation)
2,419.60
2,360.20
2,287.70
2,393.20
1,976.06
1,385.79
1,091.06
Operating Profit (PBDIT) excl Other Income
547.9
419.79999999999995
487.8
1099.5
910.9000000000001
524.3
349.5
Other Income
-6.30
8.70
-22.50
-28.10
-225.88
-26.68
2.54
Operating Profit (PBDIT)
860.80
730.20
702.10
1,254.80
828.34
600.09
426.02
Interest
152.70
158.90
121.10
41.00
23.68
37.73
19.95
Exceptional Items
-14.60
-41.80
57.70
98.30
-16.38
0.02
-15.28
Gross Profit (PBDT)
1,345.30
1,206.70
1,234.00
1,834.50
1,553.00
1,003.32
748.29
Depreciation
318.10
301.70
236.80
181.70
141.56
101.69
73.37
Profit Before Tax
375.40
227.80
401.90
1,130.40
646.72
460.69
317.42
Tax
107.30
40.70
89.20
250.50
232.41
122.10
81.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
265.60
175.10
310.30
876.10
414.41
335.93
234.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
265.60
175.10
310.30
876.10
414.41
335.93
234.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.30
3.40
2.40
3.80
-0.10
2.67
1.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
265.90
178.50
312.70
879.90
414.31
338.60
236.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
4,090.50
3,986.60
2,638.50
2,449.30
1,655.87
1,438.12
1,158.72
Earnings per share (EPS)
2.73
1.81
3.37
9.51
4.5
3.64
2.54
Diluted Earnings per share
2.73
1.81
3.37
9.51
4.5
3.64
2.54
Operating Profit Margin (Excl OI)
18.5%
15.1%
17.58%
31.53%
31.61%
27.49%
24.3%
Gross Profit Margin
23.37%
19.05%
23.01%
37.57%
27.3%
29.44%
27.13%
PAT Margin
8.95%
6.3%
11.18%
25.08%
14.35%
17.59%
16.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 6.74% vs 0.16% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 48.96% vs -42.92% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 20.18% vs -0.43% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -3.90% vs 31.21% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Sartorius Stedim Biotech SA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
2,967.50
28,491.00
-25,523.50
-89.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,967.50
28,491.00
-25,523.50
-89.58%
Raw Material Cost
1,622.20
11,237.00
-9,614.80
-85.56%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
855.90
0.00
855.90
Power Cost
0
0
0.00
Manufacturing Expenses
152.70
239.00
-86.30
-36.11%
Selling and Distribution Expenses
664.80
13,229.00
-12,564.20
-94.97%
Other Expenses
-87.60
42.50
-130.10
-306.12%
Total Expenditure (Excl Depreciation)
2,419.60
25,130.00
-22,710.40
-90.37%
Operating Profit (PBDIT) excl Other Income
547.90
3,361.00
-2,813.10
-83.70%
Other Income
-6.30
73.00
-79.30
-108.63%
Operating Profit (PBDIT)
860.80
6,547.00
-5,686.20
-86.85%
Interest
152.70
239.00
-86.30
-36.11%
Exceptional Items
-14.60
0.00
-14.60
Gross Profit (PBDT)
1,345.30
17,254.00
-15,908.70
-92.20%
Depreciation
318.10
3,113.00
-2,794.90
-89.78%
Profit Before Tax
375.40
3,195.00
-2,819.60
-88.25%
Tax
107.30
752.00
-644.70
-85.73%
Provisions and contingencies
0
0
0.00
Profit After Tax
265.60
2,315.00
-2,049.40
-88.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
265.60
2,315.00
-2,049.40
-88.53%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.30
128.00
-127.70
-99.77%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
265.90
2,443.00
-2,177.10
-89.12%
Equity Capital
0
0
0.00
Face Value
0.20
0.00
0.00
Reserves
4,090.50
38,889.00
-34,798.50
-89.48%
Earnings per share (EPS)
2.73
4.98
-2.25
-45.18%
Diluted Earnings per share
2.73
4.98
-2.25
-45.18%
Operating Profit Margin (Excl OI)
18.50%
11.80%
0.00
6.70%
Gross Profit Margin
23.37%
22.14%
0.00
1.23%
PAT Margin
8.95%
8.13%
0.00
0.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 296.75 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 6.74% vs 0.16% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 26.59 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 48.96% vs -42.92% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 86.71 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.18% vs -0.43% in Dec 2024

Annual - Interest
Interest 15.27 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.90% vs 31.21% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.50%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024